BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35587536)

  • 1. Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study.
    Popov J; Coelho S; Carrier M; Sperlich C; Solymoss S; Routhier N; Shivakumar S; Aibibula W; Kahn SR; Tagalakis V
    J Thromb Haemost; 2022 Aug; 20(8):1868-1874. PubMed ID: 35587536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study.
    Klamroth R; Sinn M; Pollich C; Bischoff S; Lohneis A; Orlovic AM; Wisłocka L; Habbel P; de Wit M; Späth-Schwalbe E; Scholz CW; Riess H
    Oncol Res Treat; 2022; 45(4):178-185. PubMed ID: 34963120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT).
    Noble SI; Nelson A; Fitzmaurice D; Bekkers MJ; Baillie J; Sivell S; Canham J; Smith JD; Casbard A; Cohen A; Cohen D; Evans J; Fletcher K; Johnson M; Maraveyas A; Prout H; Hood K
    Health Technol Assess; 2015 Oct; 19(83):vii-xxiii, 1-93. PubMed ID: 26490434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
    Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study.
    Monreal M; Büller H; Lensing AW; Bonet M; Roncales J; Muchart J; Fraile M
    Thromb Haemost; 2002 Dec; 88(6):938-42. PubMed ID: 12529742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis.
    Singh K; Yakoub D; Giangola P; DeCicca M; Patel CA; Marzouk F; Giangola G
    J Vasc Surg; 2012 Jan; 55(1):136-40. PubMed ID: 21982332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients.
    Lee TH; Alonzo BJ; Differding J; Underwood SJ; Hamilton G; Kremenevskiy I; McNamara S; Schreiber MA
    J Trauma Acute Care Surg; 2013 Feb; 74(2):476-81. PubMed ID: 23354241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD005259. PubMed ID: 35993965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ
    Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.